The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Review of cancer from perspective of molecular
Open accessAbstract
Cancer in the broader sense refers to more than 277 different types of cancer disease. Scientists have identified different stage of cancers, indicating that several gene mutations are involved in cancer pathogenesis. These gene mutations lead to abnormal cell proliferation. Genetic disorders caused by heritance or inheritance factors have a pivotal role in the increase of cell growth. With the assistance of technological advances in bioinformatics and molecular techniques, additional information has been obtained that can be useful for early diagnosis and proper treatment. The effects of drugs on patients with cancer can predict and even manage some aspects of side effects. In recent years, carcinogenesis mechanisms have been detected by molecular genetic studies. The results of these studies led to an improved understanding of the role of genetic disorders in cancer formation. In this study, our aim was to review molecular aspects of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Cancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Epigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,836
Sharma, S., Kelly, T. K., & Jones, P. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp220 · Cited by 2,637
Tumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
Shtivelman, E., Lifshitz, B., Gale, R. P., & Canaani, E. (1985) · Nature · doi:10.1038/315550a0 · Cited by 1,611
Regulation of the G2/M transition by p53
Taylor, W. R., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204252 · Cited by 1,559
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545
Wood, R. D., Mitchell, M., Sgouros, J., & Lindahl, T. (2001) · Science · doi:10.1126/science.1056154 · Cited by 1,466
Doi, A., Park, I.-H., Wen, B., Murakami, P., Aryee, M. J., Irizarry, R., Herb, B., Ladd-Acosta, C., Rho, J., Loewer, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.471 · Cited by 1,177
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173 · cited 1×
“In addition, disabling mutations in SETD2 (a histone methyltransferase) and UTX (a histone demethylase) occurs during renal carcinoma ((50)).”
BackgroundAmplification of a Novel v- erb B-Related Gene in a Human Mammary Carcinoma
King, C. R., Kraus, M. H., & Aaronson, S. A. (1985) · Science · doi:10.1126/science.2992089 · Cited by 1,072
High-throughput oncogene mutation profiling in human cancer
Thomas, R. K., Baker, A. C., DeBiasi, R. M., Winckler, W., LaFramboise, T., Lin, W. M., Wang, M., Feng, W., Zander, T., MacConaill, L. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1975 · Cited by 988
Cancer heterogeneity: implications for targeted therapeutics
Fisher, R., Pusztai, L., & Swanton, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.581 · Cited by 978
Cancer Epidemiology and Prevention.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-1-140_1 · Cited by 952
Hypomethylation of DNA from Benign and Malignant Human Colon Neoplasms
Goelz, S. E., Vogelstein, B., Hamilton, S. R., & Feinberg, A. P. (1985) · Science · doi:10.1126/science.2579435 · Cited by 840
DNA hypomethylation and human diseases
Wilson, A. S., Power, B. E., & Molloy, P. L. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.007 · Cited by 804
Epigenetic gene silencing in cancer: the DNA hypermethylome
Esteller, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm018 · Cited by 725 · cited 1×
“These events have a pivotal role in the induction of cancer ((42)).”
BackgroundTwenty years of p53 research: structural and functional aspects of the p53 protein
May, P., & May, E. (1999) · Oncogene · doi:10.1038/sj.onc.1203285 · Cited by 663
Heinrich, M. C., Blanke, C. D., Druker, B. J., & Corless, C. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1692 · Cited by 634
Localization of gene for human p53 tumour antigen to band 17p13
Isobe, M., Emanuel, B. S., Givol, D., Oren, M., & Croce, C. M. (1986) · Nature · doi:10.1038/320084a0 · Cited by 485
Roninson, I. B. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00847-3 · Cited by 443
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer
Noonan, E. J., Place, R. F., Pookot, D., Basak, S., Whitson, J. M., Hirata, H., Giardina, C., & Dahiya, R. (2009) · Oncogene · doi:10.1038/onc.2009.19 · Cited by 396
The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13).
McBride, O. W., Merry, D., & Givol, D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.1.130 · Cited by 365
Wang, P., Lin, C., Smith, E. R., Guo, H., Sanderson, B. W., Wu, M., Gogol, M., Alexander, T., Seidel, C., Wiedemann, L. M., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00924-09 · Cited by 361
Sensitive digital quantification of DNA methylation in clinical samples
Li, M., Chen, W.-D., Papadopoulos, N., Goodman, S. N., Bjerregaard, N. C., Laurberg, S., Levin, B., Juhl, H., Arber, N., Moinova, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1559 · Cited by 341
Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.
Matlashewski, G., Lamb, P., Pim, D., Peacock, J., Crawford, L., & Benchimol, S. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02287.x · Cited by 299
NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs
Vaquero, A., Sternglanz, R., & Reinberg, D. (2007) · Oncogene · doi:10.1038/sj.onc.1210617 · Cited by 296
Cancer genetics of epigenetic genes
Miremadi, A., Oestergaard, M. Z., Pharoah, P. D. P., & Caldas, C. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm021 · Cited by 249
Cumberbatch, M. G. K., Cox, A., Teare, D., & Catto, J. W. F. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.3209 · Cited by 242
Kanai, Y., & Hirohashi, S. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm206 · Cited by 220
Kondo, Y., Shen, L., Suzuki, S., Kurokawa, T., Masuko, K., Tanaka, Y., Kato, H., Mizuno, Y., Yokoe, M., Sugauchi, F., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00141.x · Cited by 203
Histone macroH2A isoforms predict the risk of lung cancer recurrence
Sporn, J. C., Kustatscher, G., Hothorn, T., Collado, M., Serrano, M., Muley, T., Schnabel, P., & Ladurner, A. G. (2009) · Oncogene · doi:10.1038/onc.2009.26 · Cited by 175
Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas
Cigudosa, J. C., Parsa, N. Z., Louie, D. C., Filippa, D. A., Jhanwar, S. C., Johansson, B., Mitelman, F., & Chaganti, R. S. K. (1999) · Genes Chromosomes and Cancer · Cited by 168
Espada, J., Ballestar, E., Santoro, R., Fraga, M. F., Villar‐Garea, A., Németh, A., Lopez-Serra, L., Ropero, S., Aranda, A., Orozco, H., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm118 · Cited by 158
Exposure to environmental chemicals and heavy metals, and risk of pancreatic cancer
Antwi, S. O., Eckert, E. C., Sabaque, C., Leof, E. R., Hawthorne, K. M., Bamlet, W. R., Rabe, K. G., Oberg, A. L., & Petersen, G. M. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0652-y · Cited by 152
Floral Morphogenesis: Stochastic Explorations of a Gene Network Epigenetic Landscape
Alvarez-Buylla, E. R., Chaos, Á., Aldana, M., Benítez, M., Cortés-Poza, Y., Espinosa‐Soto, C., Hartasánchez, D. A., Lotto, R. B., Malkin, D., Santos, G. J. E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003626 · Cited by 136
Poon, S. L., McPherson, J. R., Tan, P. B. O., Teh, B. T., & Rozen, S. (2014) · Genome Medicine · doi:10.1186/gm541 · Cited by 126
Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas
Bukholm, I. K., & Nesland, J. M. (2000) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050034 · Cited by 126
Tyrosine kinase inhibitor imatinib (STIS71) as an anticancer agent for solid tumours
Joensuu, H., & Dimitrijević, S. (2001) · Annals of Medicine · doi:10.3109/07853890109002093 · Cited by 120
Koshland, D. E. (1993) · Science · doi:10.1126/science.8266084 · Cited by 115
Aizawa, K., Liu, C., Tang, S., Veeramachaneni, S., Hu, K., Smith, D. E., & Wang, X. (2016) · International Journal of Cancer · doi:10.1002/ijc.30161 · Cited by 104
Aberrant Methylation of the Maspin Promoter Is an Early Event in Human Breast Cancer
Futscher, B. W., O'Meara, M. M., Kim, C. J., Rennels, M. A., Lu, D., Gruman, L. M., Seftor, R. E. B., Hendrix, M. J. C., & Domann, F. E. (2004) · Neoplasia · doi:10.1593/neo.04115 · Cited by 73
Diversity of genome profiles in malignant lymphoma
Seto, M., Honma, K., & Nakagawa, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01452.x · Cited by 59
Chae, S. W., Sohn, J. H., Kim, D., Choi, Y. J., Park, Y. L., Kim, K., Cho, Y. H., Pyo, J., & Kim, J. H. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2011.52.3.445 · Cited by 58
Selivanova, G. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043332934 · Cited by 49
Dietary exposure to meat-related carcinogenic substances: is there a way to estimate the risk?
Trafiałek, J., & Kolanowski, W. (2014) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2014.917146 · Cited by 36
Cited by
Natural Products as Anticancer Agents: Current Status and Future Perspectives
Naeem, A., Hu, P., Yang, M., Zhang, J., Liu, Y., Zhu, W., & Zheng, Q. (2022) · Molecules · doi:10.3390/molecules27238367 · Cited by 607
Mäder, P., & Kattner, L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00960 · Cited by 438
Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents
Hashem, S., Ali, T. A., Akhtar, S., Nisar, S., Sageena, G., Ali, S., Al-Mannai, S., Therachiyil, L., Mir, R., Elfaki, I., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113054 · Cited by 377
Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
Mahmoodi Chalbatani, G., Dana, H., Gharagouzloo, E., Grijalvo, S., Eritja, R., Logsdon, C. D., Memari, F., Miri, S. R., Rezvani Rad, M., & Marmari, V. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200253 · Cited by 221
Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy
Mohanty, A., Uthaman, S., & Park, I.-K. (2020) · Molecules · doi:10.3390/molecules25194377 · Cited by 160
Metadata
- Authors
- Hassanpour, S. H., & Dehghani, M.
- Venue
- Journal of Cancer Research and Practice
- Publisher
- Medknow
- Published
- 2017-12
- Volume
- 4
- Issue
- 4
- Pages
- 127-129
- ISSN
- 2311-3006 (ISSN-L)
- OpenAlex
- W2735767394
- Cited by
- 683
- References
- 49
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.